abstract |
The present invention relates to a method of treating a subject having heart failure with retained ejection fraction (HFpEF) with a sustained delivery formulation of 5- (pyridinyl) -2 (1H) -pyridinone compound as a cardiotonic agent. [Selection figure] None |